Search hospitals > Utah > Salt Lake City
Primary Children's Hospital
Claim this profileSalt Lake City, Utah 84113
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Solid Tumors
412 reported clinical trials
33 medical researchers
Summary
Primary Children's Hospital is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Primary Children's Hospital is involved with conducting 412 clinical trials across 650 conditions. There are 33 research doctors associated with this hospital, such as Matthew Dietz, Luke D. Maese, Michael Pulsipher, MD, and Priya Chan.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Top PIs
Matthew DietzPrimary Children's Hospital8 years of reported clinical research
Expert in Neuroblastoma
Expert in Cancer
33 reported clinical trials
64 drugs studied
Luke D. MaesePrimary Children's Hospital5 years of reported clinical research
Studies Brain Tumor
Studies Burkitt Lymphoma
23 reported clinical trials
56 drugs studied
Michael Pulsipher, MDChildren's Hospital Los Angeles6 years of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Leukemia
16 reported clinical trials
31 drugs studied
Priya ChanPrimary Children's Hospital3 years of reported clinical research
Studies Brain Tumor
Studies Brain Cancer
10 reported clinical trials
22 drugs studied
Clinical Trials running at Primary Children's Hospital
Brain Tumor
Neuroblastoma
Testicular cancer
Cancer
Wilms Tumor
Burkitt Lymphoma
Leukemia
Acute Lymphoblastic Leukemia
Brain Cancer
Acute Myeloid Leukemia
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selinexor + Radiation
for Brain Cancer
This trial tests the safety and effectiveness of combining selinexor with radiation therapy in children and young adults with aggressive brain tumors. Selinexor is a drug that blocks a protein to stop cancer cells from growing. The study aims to find the best dose and see if this combination can shrink tumors.
Recruiting1 award Phase 1 & 21 criteria
Risk-Directed Therapy
for Medulloblastoma
This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medulloblastoma.
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Primary Children's Hospital?
Primary Children's Hospital is a medical facility located in Salt Lake City, Utah. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Acute Lymphoblastic Leukemia, Solid Tumors and other specialties. Primary Children's Hospital is involved with conducting 412 clinical trials across 650 conditions. There are 33 research doctors associated with this hospital, such as Matthew Dietz, Luke D. Maese, Michael Pulsipher, MD, and Priya Chan.
Where is Primary Children's Hospital located?
**Primary Children's Hospital**
- **Address:** 100 Mario Capecchi Drive, Salt Lake City, UT 84113.
- **Public Transportation:** Accessible by public transportation. The nearest light rail station is University South Campus Station, approximately a 17-minute walk away.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at Primary Children's Hospital, please use the following contact information:
- **Financial Assistance:** (614) 722-2070
- **Hospital Care Assurance Program (HCAP):** (614) 722-2055, for individuals with income below 100% of the poverty level who are not eligible for Medicaid.
- **Healthy Start and Healthy Families:** (614) 722-6855, providing free or low-cost health care coverage to families, children under age 19, and pregnant women.
- **Customer Service for Billing and Insurance:** (614) 722-2055
What insurance does Primary Children's Hospital accept?
Primary Children's Hospital accepts a wide range of insurance plans, including Medicaid/Children's Health Insurance Program (CHIP). Accepted insurance providers include Aetna, AmeriHealth, Cigna, Empire Blue Cross, Horizon BCBS, Oxford Health Plans, United Health Care, and more. For behavioral health services, the hospital accepts SelectHealth, EMI, PEHP, DMBA, and BCBS. It is advised to contact the hospital or your insurance provider to confirm specific coverage details.
What awards or recognition has Primary Children's Hospital received?
Primary Children's Hospital, located in Salt Lake City, Utah, has been awarded Magnet Recognition, the highest national honor for nursing excellence, by the American Nurses Credentialing Center's Magnet Recognition ProgramĀ®. This prestigious award underscores the hospital's dedication to exceptional patient care, nursing professionalism, and effective teamwork. Furthermore, the hospital partners with the University of Utah School of Medicine to conduct pediatric research, notably in the University Child Abuse Recognition & Education program.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.